Cyclooxygenase-2 Facilitates Newcastle Disease Virus Proliferation and Is as a Target for Canthin-6-One Antiviral Activity

Frontiers in Microbiology
Chongyang WangJunru Wang

Abstract

Cyclooxygenase-2 (COX-2), one of the mediators of inflammation in response to viral infection, plays an important role in host antiviral defense system. But its role in Newcastle disease virus (NDV) proliferation process remains unclear. This study revealed that inhibition of COX-2 could benefit NDV proliferation and overexpression of COX-2 dose-dependently suppressed NDV proliferation. Overexpression of COX-2 also showed inhibitory effect on NDV-induced endoplasmic reticulum (ER)-stress and autophagy, also promoted the expression of antiviral genes. However, prostaglandin E2 (PGE2), the major product of COX-2, had indistinctive effects on NDV proliferation. At variant time point post viral infection, a tight regulation pattern of COX-2 by NDV was observed. Using inhibitors and siRNA against signaling molecules, the nuclear factor-κB (NF-κB) and melanoma differentiation-associated gene 5 (MDA5) were identified as critical factors for NDV induced COX-2 expression. Nonetheless, at late stage of NDV proliferation, substantial suppression of COX-2 protein synthesis could be detected, accompanied by a decrease in mRNA half-life. Furthermore, three C ring-truncated canthin-6-one analogs were used to activate COX-2 expression and show...Continue Reading

References

Jun 17, 1999·Nature Medicine·D W GilroyD A Willoughby
Aug 5, 2000·Research in Veterinary Science·K KatsudaM Eguchi
Mar 14, 2002·Biochemical and Biophysical Research Communications·Tadaatsu ImaizumiKei Satoh
Mar 20, 2002·Cancer Practice·A M Valorie
Apr 9, 2002·Prostaglandins & Other Lipid Mediators·Nannan ChenCarol Shoshkes Reiss
Jan 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sarah A SteerJohn A Corbett
Aug 7, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Karen RiedlSteven M Dubinett
Nov 16, 2004·Journal of Virology·Neelanjana RayL W Enquist
Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jörg Schröer, Thomas Shenk
Jan 6, 2009·Immunological Reviews·Osamu Takeuchi, Shizuo Akira
Apr 22, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Emanuela Ricciotti, Garret A FitzGerald
Jan 29, 2014·Journal of Natural Products·Thi Van Anh TranHermann Stuppner
Apr 22, 2014·Immunity·Florian Full, Michaela U Gack
Sep 8, 2015·Cell·Santiago ZelenayCaetano Reis e Sousa
Sep 24, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuqiang ChengJianhe Sun
Dec 20, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Nowshin N Rumzhum, Alaina J Ammit
Apr 20, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jiangkun DaiUwe Schneider
Jun 7, 2016·Scientific Reports·Sabine Eva DudekChristina Ehrhardt
Jun 12, 2017·Current Opinion in Virology·Robert M Cox, Richard K Plemper
Nov 28, 2017·Planta medica·Seung-Kye ChoJung-Hye Choi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
electrophoresis
ELISA

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms